111 (Phospho)proteomics biomarkers for sunitinib response in RCC 77 Mertins, P. et al. Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels. Mol Cell Proteomics 13, 1690-1704, doi:10.1074/mcp.M113.036392 (2014). 78 Buccitelli, C. & Selbach, M. mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet 21, 630-644, doi:10.1038/s41576-020-0258-4 (2020). 79 Petralia, F. et al. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer. Cell 183, 1962-+, doi:10.1016/j.cell.2020.10.044 (2020). 80 Xu, J. N., Wendel, H. G., Pelletier, J., Yao, Z. & Rosen, N. eIF4A regulates ERK activation by controlling the translation of DUSP6. Mol Cancer Ther 18, doi:10.1158/1535-7163.Targ-19-B075 (2019). 81 Koster, B. D. et al. Autologous tumor cell vaccination combined with systemic CpG-B and IFN-alpha promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial. Cancer Immunol Immunother 68, 1025-1035, doi:10.1007/s00262-01902320-0 (2019). 82 Lopez-Beltran, A. et al. The Identification of Immunological Biomarkers in Kidney Cancers. Front Oncol 8, doi:ARTN 456 10.3389/fonc.2018.00456 (2018). 83 Chen, F. J. et al. Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Rep 14, 24762489, doi:10.1016/j.celrep.2016.02.024 (2016). 84 An, H. J. et al. Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma. Sci Rep-Uk 9, doi:ARTN 12656 10.1038/s41598-019-48968-7 (2019). 85 Song, D. H. et al. Prognostic role of myoferlin expression in patients with clear cell renal cell carcinoma. Oncotarget 8, 89033-89039, doi:10.18632/oncotarget.21645 (2017). 86 Bruggemann, M. et al. Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma. Transl Oncol 10, 661-668, doi:10.1016/j. tranon.2017.06.002 (2017). 87 Solarek, W., Koper, M., Lewicki, S., Szczylik, C. & Czarnecka, A. M. Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators. J Cell Commun Signal 13, 381-394, doi:10.1007/ s12079-019-00512-y (2019). 88 Bleu, M. et al. PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma. Nature Communications 10, doi:ARTN 3739 10.1038/s41467-019-11672-1 (2019). 89 Filipovic, J. et al. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance. Diagn Pathol 14, doi:ARTN 120 10.1186/s13000-019-0901-6 (2019). 90 Liu, C. H. et al. BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1. Oncology Letters 10, 619-624, doi:10.3892/ol.2015.3293 (2015). 91 Cui, H. et al. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma. Sci Rep-Uk 10, doi:ARTN 4271 10.1038/s41598-020-61162-4 (2020). 4
RkJQdWJsaXNoZXIy MTk4NDMw